RVP Stock Overview
Designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Retractable Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.72 |
| 52 Week High | US$1.22 |
| 52 Week Low | US$0.56 |
| Beta | 2.28 |
| 1 Month Change | 3.35% |
| 3 Month Change | -9.39% |
| 1 Year Change | -32.87% |
| 3 Year Change | -81.17% |
| 5 Year Change | -85.35% |
| Change since IPO | -94.31% |
Recent News & Updates
Recent updates
Is Retractable Technologies (NYSEMKT:RVP) Using Too Much Debt?
Mar 16
Do Insiders Own Lots Of Shares In Retractable Technologies, Inc. (NYSEMKT:RVP)?
Feb 26Retractable Technologies (NYSEMKT:RVP) Knows How To Allocate Capital Effectively
Feb 08Here's Why I Think Retractable Technologies (NYSEMKT:RVP) Might Deserve Your Attention Today
Jan 12
Here's Why We Don't Think Retractable Technologies's (NYSEMKT:RVP) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 28Does Retractable Technologies (NYSEMKT:RVP) Have A Healthy Balance Sheet?
Dec 14How Should Investors React To Retractable Technologies' (NYSEMKT:RVP) CEO Pay?
Dec 01Shareholder Returns
| RVP | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.1% | 6.0% | 7.1% |
| 1Y | -32.9% | 6.0% | 7.7% |
Return vs Industry: RVP underperformed the US Medical Equipment industry which returned 6.1% over the past year.
Return vs Market: RVP underperformed the US Market which returned 7.5% over the past year.
Price Volatility
| RVP volatility | |
|---|---|
| RVP Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 9.4% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: RVP has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RVP's weekly volatility (6%) has been stable over the past year.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 224 | Thomas Shaw | www.retractable.com |
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network.
Retractable Technologies, Inc. Fundamentals Summary
| RVP fundamental statistics | |
|---|---|
| Market cap | US$22.46m |
| Earnings (TTM) | -US$12.12m |
| Revenue (TTM) | US$33.05m |
0.7x
P/S Ratio-1.8x
P/E RatioIs RVP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RVP income statement (TTM) | |
|---|---|
| Revenue | US$33.05m |
| Cost of Revenue | US$34.08m |
| Gross Profit | -US$1.03m |
| Other Expenses | US$11.09m |
| Earnings | -US$12.12m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.40 |
| Gross Margin | -3.11% |
| Net Profit Margin | -36.66% |
| Debt/Equity Ratio | 1.4% |
How did RVP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/28 12:51 |
| End of Day Share Price | 2025/04/28 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Retractable Technologies, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.